Mineralocorticoid Receptor Antagonists

DBCAT000844Therapeutic categoryC03DA

Drugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE. A DrugBank category of 6 drugs. 5 of them are approved.

ATC classification: C — CARDIOVASCULAR SYSTEM
C03 — DIURETICS
C03D — ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS
C03DA — Aldosterone antagonists
Also known as: Aldosterone Antagonists · Aldosterone Receptor Antagonists · Antagonists, Aldosterone · Antagonists, Aldosterone Receptor · Antagonists, Mineralocorticoid
Drugs: Canrenoic acid
Canrenone
Drospirenone
Eplerenone
Finerenone
Spironolactone

What you can answer from here — as of August 16, 2019

6DrugsEach linked to its full drug card

Listed above

10Drug targetsEvery drug–target pair in the class, with bond type

1,622Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

1SubcategoryNarrower classes within this one

Which targets do Mineralocorticoid Receptor Antagonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account